Edgen Stock·Dec 01 2025, 10:04Back
Intellia Faces FDA Hold on Nex-Z Trials Amid Progress in Lonvo-z Gene Therapy Pipeline
Edgen Stock·Dec 01 2025, 10:04
[1] Intellia Therapeutics Announces Third Quarter 2025 Financial ... (https://www.biospace.com/press-releases/intel ...)[2] Intellia Completes Phase 3 HAELO Trial Enrollment for Lonvo-z (https://www.pharmanow.live/latest-news/intell ...)[3] Intellia completes enrollment in phase 3 HAE gene therapy trial (https://www.investing.com/news/company-news/i ...)
